
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro
PIOMBINO DESE, Italy – Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that its Board of Directors has appointed Franco Stevanato, a current director and the Executive Chairman of the Company, as its new Chief Executive Officer. Mr. Stevanato is succeeding as Chief Executive Officer Franco … Continue reading Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro